x
 
 
 
 

About Us

Scientific Advisors

photo team

Luca Benatti, Ph.D.

SAB Chairman

Dr. Benatti has over 30 years of experience in the pharmaceutical and biotechnology industries. He serves as the Chief Executive Officer and a Director of EryDel S.p.A., a private biotechnology company focused on rare diseases. Prior to EryDel, Dr. Benatti was Co-founder and CEO of Newron Pharmaceuticals S.p.A. Under his leadership, Newron developed a pipeline of innovative therapies including Xadago, approved worldwide for the treatment of Parkinson's Disease. Previously, Dr. Benatti held research and development positions at Pharmacia & Upjohn and its predecessor companies. Dr. Benatti has authored several scientific publications and holds a number of patents. He currently serves as a director of Intercept Pharmaceuticals, Newron Pharmaceuticals S.p.A. and Metis Precision Medicine. Dr. Benatti also serves as chairman of Italian Angels for Biotech, a member of the Advisory Board of the Sofinnova Telethon Fund, and as a member of the Development and of the Strategic Advisory Boards of Zambon S.p.A. Dr. Benatti graduated and performed post-doctoral work at the Milano Genetics Institute.

 

 
 
 

Research and Development Collaborations

lilly 

 

Grants

Grants Grants Grants Grants

 

Patient Associations

Patient Associations Patient Associations Patient Associations Patient Associations

Centers of Research, Translational Science & Clinical Excellence

Centers of Research Centers of Research Centers of Research Centers of Research Centers of Research Centers of Research
Centers of Research Centers of Research Centers of Research Centers of Research Centers of Research Centers of Research
 

Interested in working with a dynamic team of research,
medical and business professionals? 

View Job opportunities